Xinlitai: The controlling shareholder has released a pledge of 3.86% of the shares.

Xinlitai Announcement: The company's controlling shareholder, Xinlitai Pharmaceutical Co., Ltd., has released a pledge of 43 million shares, accounting for 6.77% of its holdings and 3.86% of the company's total share capital. The pledge period is from October 10, 2022, to February 2, 2026, with the pledgee being the Bank of South Asia Limited. After the release, its cumulative pledged shares amount to 54 million, accounting for 8.50% of holdings and 4.84% of the company's total share capital. It holds 635 million shares of the company, accounting for 56.99%.